Skip to the page

Data / Form D filings / Silenseed Ltd.

Silenseed Ltd.: Form D filing

Silenseed Ltd., a biotechnology company in Jerusalem, Israel, filed a Form D with the SEC in 2014. The latest, on April 8, 2014, reports $500,000 sold of a $500,000 offering to 4 investors.

Find out what Silenseed Ltd. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
GOLDYNE SAVAD INSTITUTE OF GENE THERAPY, HADASSAH MEDICAL CENTER EIN KEREM, Jerusalem, Israel, 91120
Phone
972 2 6743430
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Israel
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1602634

The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 8, 2014New notice$500,000$500,000$04Mar 25, 2014sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Amotz ShemiExecutive Officer, Director
Eithan GalunDirector
Shmuel CabillyDirector
Ilan ShiloahDirector

Every Form D from the week of Apr 7, 2014 · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Silenseed Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.